Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats

Indian Journal of Pharmacology

Volumn 44, Issue 2, 2012, Pages 246-252

  Dilip Reddy, G ^a   Gopala Reddy, A ^a   Rao, G S ^b   Vijay Kumar, M ^c  

^a Pandit Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwa Vidyalaya Evum Go Anusandhan Sansthan   (India)

^b NTR College of Veterinary Science   (India)

^c VETERINARY COLLEGE   (India)

Author keywords

Atorvastatin; garlic; pharmacokinetics

Indexed keywords

ATORVASTATIN; CYTOCHROME P450;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG ELIMINATION; DYSLIPIDEMIA; FOOD DRUG INTERACTION; GARLIC; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

EID: 84858980968     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.93860     Document Type: Article

References (19)

1. th ed. New York, USA: McGraw Hill; 2006. p. 933-60.
2. Malhotra HS, Goa KL. Atorvastatin: An updated review of its pharmacological properties and use in dyslipidaemia. Drug evaluation. Drugs 2001;61:1835-81. (Pubitemid 32980510)
3. Alaupovic P, Heinonen T, Shurzinske L, Black DM. Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels. Atherosclerosis 1997;133:123-33. (Pubitemid 27322126)
4. Reuter HD. Allium sativum and Allium ursinum, part 2: Pharmacology and medicinal applications. Phytomedicine 1995;2:73-91.
5. Augusti KT, Chackery J, Jacob J, Kuriakose S, George S, Nair SS. Beneficial effects of a polar fraction of garlic (Allium sativum Linn) oil in rats fed with two different high fat diets. Indian J Exp Biol 2005;43:76-83. (Pubitemid 40078312)
6. Thomson M, Al-Qattan KK, Bordia T, Ali M. Including garlic in the diet may help lower blood glucose, cholesterol, and triglycerides. J Nutr 2006;136:800S-2.
7. Lanzotti V. The analysis of onion and garlic. J Chromatogr A 2006;1112:3-22.
8. Jani A, Mehta A. Pharmacology of Allium sativum in relation to Cytochrome P450 and possible drug interactions. Pharmacognosy Rev 2007;2:222-6.
9. Foster BC, Foster MS, Vandenhoek S, Krantis A, Budzinski JW, Arnason JT, et al. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharm Sci 2001;4:159-67.
10. Bahrami G, Mohammadi B, Mirzaeei S, Kiani A. Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detection. J Chromatogr B 2005;826:41-5. (Pubitemid 41446432)
11. nd ed. New York: Marcel Dekker; 1982.
12. th ed., Taylor and Francis, Philadelphia, USA, 2001. p. 1588.
13. Choi SJ, Kim M, Kim SI, Jeon JK. Microplate assay measurement of cytochrome P450-Carbon monoxide complexes. J Biochem Mol Biol 2003;36:332-5. (Pubitemid 36890834)
14. Lennernas H, Fager G. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinetics 1997;32:403-25. (Pubitemid 27199232)
15. Lea AP, McTavish D. Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidemias. Drugs 1997;53:828-47. (Pubitemid 27195013)
16. Dostal LA, Whitfield LR, Anderson JA. Fertility and general reproduction studies in rats with the HMG-CoA reductase inhibitor, atorvastatin. Fundam Appl Toxicol 1996;32:285-92.
17. Reddy GD, Reddy AG, Rao GS, Haritha C, Jyothi K. Interaction study on garlic and atorvastatin with reference to nephrotoxicity in dyslipidaemic rats. Toxicol Int 2010;17:90-3.
18. Lau YY, Huang Y, Frassetto L, Benet LZ. Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. Clin Pharmacol Ther 2007;81:194-204. (Pubitemid 46174816)
19. Cheng X, Maher J, Dieter MZ, Klaassen CD. Regulation of mouse organic anion-transporting polypeptides (OATPS) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways. Drug Metab Dispos 2005;33:1276-82. (Pubitemid 41196968)